Abstract
HBV-induced upregulation of HSPA8 promotes hepatocarcinogenesis by suppressing ferroptosis and stimulating HBV replication, identifying HSPA8 as a potential therapeutic target in liver cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have